Entity Central Index Key
Convertible notes, principal amount.
Term Loan, gross.
Cover [Abstract]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Current Reporting Status
Entity Current Reporting Status
Entity Voluntary Filers
Entity Voluntary Filers
Entity Shell Company
Entity Shell Company
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Filer Category
Entity Filer Category
Entity Small Business
Entity Small Business
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Entity Public Float
Entity Public Float
Entity File Number
Entity File Number
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, Address Line Two
Entity Address Address Line2
Entity Address, City or Town
Entity Address City Or Town
Entity Address, State or Province
Entity Address State Or Province
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Entity Interactive Data Current
Entity Interactive Data Current
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Prepaid manufacturing expense current.
Accrued rebates, fees and reserve.
Statement Of Financial Position [Abstract]
Assets
Assets [Abstract]
Current assets:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Restricted cash
Restricted Cash And Cash Equivalents At Carrying Value
Trade receivables, net
Receivables Net Current
Inventory
Inventory Net
Prepaid manufacturing
Prepaid Manufacturing Expense Current
Other prepaid and other assets
Prepaid Expense And Other Assets Current
Total current assets
Assets Current
Property and equipment, net
Property Plant And Equipment Net
Inventory, non-current
Inventory Noncurrent
Operating lease right-of-use assets
Operating Lease Right Of Use Asset
Intangible assets
Intangible Assets Net Excluding Goodwill
Goodwill
Goodwill
Restricted cash, non-current
Restricted Cash And Cash Equivalents Noncurrent
Other assets, non-current
Other Assets Noncurrent
Total assets
Assets
Liabilities and Stockholders’ Equity (Deficit)
Liabilities And Stockholders Equity [Abstract]
Current liabilities:
Liabilities Current [Abstract]
Accounts payable
Accounts Payable Current
Accrued rebates, fees and reserve
Accrued Rebates Fees And Reserve Current
Accrued compensation
Employee Related Liabilities Current
Accrued liabilities
Accrued Liabilities Current
Other current liabilities
Other Liabilities Current
Total current liabilities
Liabilities Current
Contingent consideration, non-current
Business Combination Contingent Consideration Liability Noncurrent
Convertible notes
Convertible Long Term Notes Payable
Convertible notes - related parties
Notes Payable Related Parties Noncurrent
Term loan
Long Term Loans Payable
Lease liabilities, non-current
Operating Lease Liability Noncurrent
Other liabilities, non-current
Other Liabilities Noncurrent
Total liabilities
Liabilities
Commitments and contingencies (Note 8)
Commitments And Contingencies
Stockholders’ equity (deficit):
Stockholders Equity Including Portion Attributable To Noncontrolling Interest [Abstract]
Common stock, $0.0001 par value; Shares authorized: 300,000,000; Shares issued and outstanding: 70,366,661 and 68,302,681 at December 31, 2019 and 2018, respectively
Common Stock Value
Additional paid-in capital
Additional Paid In Capital Common Stock
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income Loss Net Of Tax
Accumulated deficit
Retained Earnings Accumulated Deficit
Total stockholders' equity (deficit)
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
Total liabilities and stockholders’ equity (deficit)
Liabilities And Stockholders Equity
Common stock, par value
Common Stock Par Or Stated Value Per Share
Common stock, shares authorized
Common Stock Shares Authorized
Common stock, shares issued
Common Stock Shares Issued
Common stock, shares outstanding
Common Stock Shares Outstanding
Cost of sold goods.
Income Statement [Abstract]
Statement [Table]
Statement [Table]
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Net Product Revenue
Product [Member]
Collaboration and License Revenue
License And Service [Member]
Statement [Line Items]
Statement [Line Items]
Revenue:
Revenues [Abstract]
Total revenue
Revenue From Contract With Customer Including Assessed Tax
Operating expenses:
Operating Expenses [Abstract]
Cost of goods sold
Cost Of Sold Goods
Research and development (includes related party of $52, $1,609 and $8,199 for the years ended December 31, 2019, 2018 and 2017, respectively)
Research And Development Expense
Selling, general and administrative (includes related party of $1, $181 and $62 for the years ended December 31, 2019, 2018 and 2017, respectively)
Selling General And Administrative Expense
Total operating expenses
Operating Expenses
Income (loss) from operations
Operating Income Loss
Interest expense (includes related party of $2,457, $2,421 and $2,388 for the years ended December 31, 2019, 2018 and 2017, respectively)
Interest Expense
Other income, net
Other Nonoperating Income Expense
Net income (loss) before income taxes
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Income tax provision
Income Tax Expense Benefit
Net income (loss)
Profit Loss
Net loss attributable to non-controlling interest
Net Income Loss Attributable To Noncontrolling Interest
Net income (loss) attributable to Coherus
Net Income Loss
Net income (loss) per share attributable to Coherus:
Earnings Per Share [Abstract]
Basic
Earnings Per Share Basic
Diluted
Earnings Per Share Diluted
Weighted-average number of shares used in computing net income (loss) per share attributable to Coherus:
Weighted Average Number Of Shares Outstanding [Abstract]
Basic
Weighted Average Number Of Shares Outstanding Basic
Diluted
Weighted Average Number Of Diluted Shares Outstanding
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
Research and Development Expense
Research And Development Expense [Member]
Research and development from transactions with related party
Related Party Transaction Expenses From Transactions With Related Party
Selling, general and administrative expenses from transactions with related party
Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
Interest expense from transactions with related party
Interest Expense Related Party
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)
Other comprehensive income (loss):
Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]
Foreign currency translation adjustments, net of tax
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
Comprehensive income (loss)
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
Comprehensive loss attributable to non-controlling interest
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
Comprehensive income (loss) attributable to Coherus
Comprehensive Income Net Of Tax
Statement Of Stockholders Equity [Abstract]
Equity Components
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Common Stock
Common Stock [Member]
Additional Paid-In Capital
Additional Paid In Capital [Member]
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit
Retained Earnings [Member]
Total Coherus Stockholder Equity (Deficit)
Parent [Member]
Noncontrolling Interest
Noncontrolling Interest [Member]
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Restricted Stock Units
Restricted Stock Units R S U [Member]
Two thousand eighteen bonus payout settled in restricted stock units RSUs.
2018 Bonus Payout in Restricted Stock Units
Two Thousand Eighteen Bonus Payout Settled In Restricted Stock Units R S Us [Member]
Two thousand seventeen bonus payout.
2017 Bonus Payout
Two Thousand Seventeen Bonus Payout [Member]
Sale of Stock
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Sale Of Stock Name Of Transaction [Domain]
Common stock offerings, net of underwriters discounts, commissions and offering costs.
Common Stock Offering, Net of Underwriters Discounts, Commission and Offering Costs
Common Stock Offerings Net Of Underwriters Discounts Commissions And Offering Costs [Member]
Private placements, net of underwriters discounts, commissions and offering costs.
Private Placement, Net of Underwriters Discounts, Commissions and Offering Costs
Private Placements Net Of Underwriters Discounts Commissions And Offering Costs [Member]
Beginning Balances
Beginning Balances, Shares
Issuance of common stock
Stock Issued During Period Value New Issues
Issuance of common stock, Shares
Stock Issued During Period Shares New Issues
Issuance of common stock upon exercise of stock options
Stock Issued During Period Value Stock Options Exercised
Issuance of common stock upon exercise of stock options, Shares
Stock Issued During Period Shares Stock Options Exercised
Issuance of common stock under the employee stock purchase plan ("ESPP")
Stock Issued During Period Value Employee Stock Purchase Plan
Issuance of common stock under the employee stock purchase plan ("ESPP"), Shares
Stock Issued During Period Shares Employee Stock Purchase Plans
Taxes paid related to net share settlement of bonuspayout in RSUs
Adjustments Related To Tax Withholding For Share Based Compensation
Taxes paid related to net share settlement of bonus payout in RSUs, Shares
Shares Paid For Tax Withholding For Share Based Compensation
Stock-based compensation expense
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Cumulative translation adjustment
Distributions to non-controlling interest
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
Purchase of the remaining non-controlling interest
Minority Interest Decrease From Redemptions
Net income (loss) attributable to Coherus
Ending Balances
Ending Balances, shares
Non-cash bonus payment settled in common stock.
Non-cash manufacturing postponement fee settled in common stock.
Non-cash operating lease expense.
Upfront and Milestone Expense Related To License and Collaboration Arrangements.
Increase decrease in receivables from collaboration and license agreement.
Increase decrease in accrued rebates, fees and reserve.
Increase decrease in accrued compensation.
Increase decrease in lease liabilities.
Increase (decrease) in advance payments under license agreement.
Upfront and milestone payments related to license and collaboration arrangements.
Payments to acquire interest in related party.
Proceeds from issuance common stock offering net of underwriters discounts, commissions and offering costs.
Purchases of property and equipment included in accounts payable and accrued liabilities.
Non-cash minority interest reflected in additional paid in capital.
Non-cash employee bonus settled in common stock.
Common stock offering costs included in accounts payable and accrued liabilities.
Manufacturing services settled in common stock.
Statement Of Cash Flows [Abstract]
Operating activities
Net Cash Provided By Used In Operating Activities [Abstract]
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Depreciation and amortization
Depreciation And Amortization
Remeasurement of fair-value contingent consideration
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
Stock-based compensation expense
Share Based Compensation
Non-cash accretion of discount on marketable securities
Accretion Amortization Of Discounts And Premiums Investments
Non-cash interest expense from amortization of debt discount
Amortization Of Debt Discount Premium
Impairment of property and equipment
Gain Loss On Sales Of Assets And Asset Impairment Charges
Excess and obsolete inventory
Inventory Write Down
Loss (gain) on disposal of property and equipment
Gain Loss On Sale Of Property Plant Equipment
Non-cash bonus payment settled in common stock
Non Cash Bonus Payment Settled In Common Stock
Non-cash manufacturing postponement fee settled in common stock
Non Cash Manufacturing Postponement Fee Settled In Common Stock
Non-cash operating lease expense
Non Cash Operating Lease Expense
Upfront and milestone expense related to license and collaboration arrangements
Upfront And Milestone Expense Related To License And Collaboration Arrangements
Changes in operating assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Trade receivables, net
Increase Decrease In Receivables
Receivables from collaboration and license agreement
Increase Decrease In Receivables From Collaboration And License Agreement
Inventory
Increase Decrease In Inventories
Prepaid manufacturing
Increase Decrease In Prepaid Expense
Other prepaid and current assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Other assets, non-current
Increase Decrease In Other Noncurrent Assets
Accounts payable
Increase Decrease In Accounts Payable Trade
Accounts payable - related parties
Increase Decrease In Accounts Payable Related Parties
Accrued rebates, fees and reserve
Increase Decrease In Accrued Rebates Fees And Reserve
Accrued compensation
Increase Decrease In Accrued Compensation
Accrued and other liabilities
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
Lease liabilities
Increase Decrease In Lease Liabilities
Deferred revenue
Increase Decrease In Contract With Customer Liability
Advance payments under license agreements
Increase Decrease In Advance Payments Under License Agreement
Other liabilities, non-current
Increase Decrease In Other Noncurrent Liabilities
Net cash provided by (used in) operating activities
Net Cash Provided By Used In Operating Activities
Investing activities
Net Cash Provided By Used In Investing Activities [Abstract]
Purchases of property and equipment
Payments To Acquire Property Plant And Equipment
Purchases of investments in marketable securities
Payments To Acquire Marketable Securities
Proceeds from maturities of investments in marketable securities
Proceeds From Sale And Maturity Of Marketable Securities
Upfront and milestone payments related to license and collaboration arrangements
Upfront And Milestone Payments Related To License And Collaboration Arrangements
Purchase of non-controlling interest related to InteKrin Russia
Payments To Acquire Interest In Subsidiaries And Affiliates
Purchase of non-controlling interest related to InteKrin Russia - related party
Payments To Acquire Interest In Related Party
Net cash used in investing activities
Net Cash Provided By Used In Investing Activities
Financing activities
Net Cash Provided By Used In Financing Activities [Abstract]
Proceeds from common stock offering, net of underwriters discounts, commissions and offering costs
Proceeds From Issuance Common Stock Offering Net Of Underwriters Discounts Commissions And Offering Costs
Proceeds from private placement
Proceeds From Issuance Of Private Placement
Proceeds from term loan, net of issuance costs
Proceeds From Debt Net Of Issuance Costs
Proceeds from issuances of common stock upon exercise of stock options
Proceeds From Stock Options Exercised
Proceeds from purchase under the employee stock purchase plan
Proceeds From Stock Plans
Taxes paid related to net share settlement of bonus payout in RSUs
Payments Related To Tax Withholding For Share Based Compensation
Net cash provided by financing activities
Net Cash Provided By Used In Financing Activities
Effect of exchange rate changes in cash, cash equivalents and restricted cash
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Cash, cash equivalents and restricted cash at beginning of period
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow information
Supplemental Cash Flow Information [Abstract]
Cash paid for interest
Interest Paid Net
Cash paid for income taxes
Income Taxes Paid Net
Supplemental disclosures of non-cash investing and financing activities
Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]
Purchase of property and equipment in accounts payable and accrued liabilities
Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities
Non-cash non-controlling interest reflected in additional paid in capital
Non Cash Minority Interest Reflected In Additional Paid In Capital
Right-of-use assets obtained in exchange for lease obligations
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
Non-cash employee bonuses settled in common stock
Non Cash Employee Bonus Settled In Common Stock
Common stock offering costs in accounts payable and accrued liabilities
Common Stock Offering Costs Included In Accounts Payable And Accrued Liabilities
Manufacturing services settled in common stock
Manufacturing Services Settled In Common Stock
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Operations
Nature Of Operations
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies
Basis Of Presentation And Significant Accounting Policies [Text Block]
Fair Value Disclosures [Abstract]
Fair Value Measurements
Fair Value Disclosures [Text Block]
Inventory Disclosure [Abstract]
Inventory
Inventory Disclosure [Text Block]
Balance Sheet Components
Supplemental Balance Sheet Disclosures [Text Block]
Revenue From Contract With Customer [Abstract]
Revenue
Revenue From Contract With Customer [Text Block]
Collaboration and license agreements.
Collaboration And License Agreements [Abstract]
Collaboration and License Agreements
Collaborative Arrangement Disclosure [Text Block]
Debt Disclosure [Abstract]
Debt Obligations
Debt Disclosure [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
Commitments And Contingencies Disclosure [Text Block]
Leases [Abstract]
Leases
Lessee Operating Leases [Text Block]
Equity [Abstract]
Stockholders' Equity
Stockholders Equity Note Disclosure [Text Block]
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Option Plans and Stock-Based Compensation
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Restructuring And Related Activities [Abstract]
Restructuring
Restructuring And Related Activities Disclosure [Text Block]
Income Tax Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Net Income (Loss) Per Share Attributable to Coherus
Earnings Per Share [Text Block]
Related Party Transactions [Abstract]
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Subsequent Events [Abstract]
Subsequent Events
Subsequent Events [Text Block]
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information
Quarterly Financial Information [Text Block]
Basis of Consolidation
Consolidation Policy [Text Block]
Liquidity policy text block.
Liquidity
Liquidity Policy [Text Block]
Use of Estimates
Use Of Estimates
Foreign Currency
Foreign Currency Transactions And Translations Policy [Text Block]
Segment reporting and revenue by geographic region.
Segment Reporting and Revenue by Geographic Region
Segment Reporting And Revenue By Geographic Region Policy [Text Block]
Cash, Cash Equivalents and Restricted Cash
Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy
Investments in Marketable Securities
Marketable Securities Policy
Trade Receivables
Receivables Policy [Text Block]
Concentration of Credit Risk
Concentration Risk Credit Risk
Fair Value of Financial Instruments
Fair Value Of Financial Instruments Policy
Inventory
Inventory Policy [Text Block]
Property and Equipment
Property Plant And Equipment Policy [Text Block]
Impairment of Long Lived Assets and Acquired Intangible Asset
Impairment Or Disposal Of Long Lived Assets Including Intangible Assets Policy Policy [Text Block]
Goodwill
Goodwill And Intangible Assets Goodwill Policy
Disclosure of accounting policy related to accrued research and development expenses.
Accrued Research and Development Expenses
Accrued Research And Development Expenses Policy [Text Block]
Revenue Recognition
Revenue Recognition Policy [Text Block]
Cost of Goods Sold
Cost Of Sales Policy [Text Block]
Research and Development Expense
Research And Development Expense Policy
License agreements policy text block.
License Agreements
License Agreements Policy [Text Block]
Selling, General and Administrative Expense
Selling General And Administrative Expenses Policy [Text Block]
Stock-Based Compensation
Share Based Compensation Option And Incentive Plans Policy
Income Taxes
Income Tax Policy [Text Block]
Net Income (Loss) per Share Attributable to Coherus
Earnings Per Share Policy [Text Block]
Comprehensive Income (Loss)
Comprehensive Income Policy Policy [Text Block]
Recent Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Basis of presentation and summary of significant accounting policies.
Basis of presentation and summary of significant accounting policies.
Basis Of Presentation And Summary Of Significant Accounting Policies [Table]
Basis Of Presentation And Summary Of Significant Accounting Policies [Table]
Adjustments for New Accounting Pronouncements
Adjustments For New Accounting Pronouncements [Axis]
Type of Adoption
Type Of Adoption [Member]
Adoption of Topic 842
Accounting Standards Update201602 [Member]
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Summary of Revenue by Geographical Region
Revenue From External Customers By Geographic Areas Table [Text Block]
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash
Schedule Of Restricted Cash And Cash Equivalents [Text Block]
Schedule of estimated useful lives of property plant and equipment.
Schedule of Estimated Useful Lives of Property Plant and Equipment
Schedule Of Estimated Useful Lives Of Property Plant And Equipment Table [Text Block]
Summary of Impact of Adoption of Topic 842 on Financial Statement
Schedule Of New Accounting Pronouncements And Changes In Accounting Principles [Text Block]
Financial Assets and Liabilities Measured on a Recurring Basis
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]
Summary of Changes in the Estimated Fair Value of Contingent Consideration
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]
Schedule of inventory current and noncurrent.
Schedule of Inventory
Schedule Of Inventory Current And Noncurrent Table [Text Block]
Schedule of balance sheet classification of Inventory.
Schedule of Balance Sheet Classification
Schedule Of Balance Sheet Classification Of Inventory Table [Text Block]
Schedule of Property and Equipment, Net
Property Plant And Equipment [Text Block]
Schedule of Accrued Liabilities
Schedule Of Accrued Liabilities Table [Text Block]
Revenue by Significant Customer
Schedules Of Concentration Of Risk By Risk Factor [Text Block]
Schedule of product sales discounts and allowances.
Activities and Ending Reserve Balances for Each Significant Category of Discounts and Allowances
Schedule Of Product Sales Discounts And Allowances Table [Text Block]
Debt Instrument [Table]
Debt Instrument [Table]
Debt Instrument
Debt Instrument [Axis]
Debt Instrument, Name
Debt Instrument Name [Domain]
Credit agreement.
Term Loan
Credit Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Components of Convertible Notes
Convertible Debt Table [Text Block]
Components of Interest Expense
Interest Income And Interest Expense Disclosure Table [Text Block]
Schedule of Future Payments on Debt
Schedule Of Maturities Of Long Term Debt Table [Text Block]
Components of Term Loan
Schedule Of Debt Table [Text Block]
Schedule of Non-Cancellable Purchase Commitment
Long Term Purchase Commitment [Text Block]
Schedule of Balance Sheet Classification of Lease Liabilities
Operating Leases Of Lessee Disclosure [Text Block]
Schedule of Maturities of Operating Lease Liabilities
Lessee Operating Lease Liability Maturity Table [Text Block]
Schedule Of Minimum Future Rental Commitments
Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]
Summary of Option Activities under 2016 and 2014 Plans
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Summary of Additional Information Related to Status of Options
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding And Exercisable Table [Text Block]
Summary of RSU Activity, under 2014 Plan
Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]
Schedule of Stock-Based Compensation Expense
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Schedule of Weighted Average Assumptions for Black-Scholes Option-Pricing Model Used in Determining Fair Value of Awards
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Components of Income (Loss) Before Income Taxes
Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]
Schedule of Provision For (Benefit From) Income Taxes
Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]
Reconciliation of Statutory U.S. Federal Rate
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Components of Net Deferred Tax Assets
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Reconciliation of Unrecognized Tax Benefits
Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]
Computation of Basic and Diluted Net Income (Loss) Per Share Attributable to the Company
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Outstanding Dilutive Potential Shares Excluded from Calculation of Diluted Net Income (Loss) Per Share Attributable to Coherus
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Schedule of Quarterly Financial Information
Schedule Of Quarterly Financial Information Table [Text Block]
Debt Security Category
Information By Category Of Debt Security [Axis]
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments
Other Than Temporary Impairment Credit Losses Recognized In Earnings Categories Of Investments [Domain]
Available-for-Sale Securities
Availableforsale Securities [Member]
Investment Type
Investment Type [Axis]
Investments
Investment Type Categorization [Member]
Investment in marketable securities.
Investment in Marketable Securities
Investment In Marketable Securities [Member]
Business Acquisition
Business Acquisition [Axis]
Business Acquisition, Acquiree
Business Acquisition Acquiree [Domain]
InteKrin Therapeutics, Inc.
InteKrin Therapeutics Inc
Inte Krin Therapeutics Inc [Member]
Finite-Lived Intangible Assets by Major Class
Finite Lived Intangible Assets By Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name
Finite Lived Intangible Assets Major Class Name [Domain]
In Process Research and Development
In Process Research And Development [Member]
Legal Entity
Legal Entity [Axis]
Entity
Entity [Domain]
Amgen Inc. and Amgen USA Inc.
Amgen
Amgen Incorporation And Amgen U S A Incorporation [Member]
Accumulated deficit
Net income (loss)
Foreign exchange gain (loss)
Foreign Currency Transaction Gain Loss Before Tax
Number of reportable segment
Number Of Reportable Segments
Number of operating segments
Number Of Operating Segments
Schedule Of Revenues From External Customers And Long Lived Assets [Table]
Schedule Of Revenues From External Customers And Long Lived Assets [Table]
Geographical
Statement Geographical [Axis]
Geographical
Segment Geographical [Domain]
United States
UNITED STATES
Rest of the world
Non Us [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues From External Customers And Long Lived Assets [Line Items]
Total cash, cash equivalents and restricted cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Interest income from marketable securities
Investment Income Interest
Schedule Of Property Plant And Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Property, Plant and Equipment, Type
Property Plant And Equipment By Type [Axis]
Property, Plant and Equipment, Type
Property Plant And Equipment Type [Domain]
Computer Equipment and Software
Computer Equipment [Member]
Furniture and Fixtures
Furniture And Fixtures [Member]
Machinery and Equipment
Machinery And Equipment [Member]
Leasehold Improvements
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property Plant And Equipment [Line Items]
Estimated useful lives
Property Plant And Equipment Useful Life
Estimated useful lives, description
Property Plant And Equipment Estimated Useful Lives
Impairment of property and equipment
Impairment Of Long Lived Assets Held For Use
Impairment of intangible assets excluding goodwill
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
Impairment of goodwill
Goodwill Impairment Loss
Royalty payment term.
Royalty payment term
Royalty Payment Term
Write-off of prepaid manufacturing costs.
Write-off of prepaid manufacturing costs
Write Off Of Prepaid Manufacturing Costs
Write-off of excess and obsolete inventory
Advertising expenses
Marketing And Advertising Expense
Description of uncertain income tax position
Income Tax Examination Likelihood Of Unfavorable Settlement
Accrued interest or Penalties
Income Tax Examination Penalties And Interest Accrued
Operating lease, right-of-use asset
Operating lease liability noncurrent
Adjustments for Change in Accounting Principle
Adjustments For Change In Accounting Principle [Axis]
Adjustments for Change in Accounting Principle
Change In Accounting Principle [Member]
Adjustments due to adoption of accounting standards update 2016-02.
Adjustments Due to the Adoption of Topic 842
Adjustments Due To Adoption Of Accounting Standards Update201602 [Member]
Balance Sheet Location
Balance Sheet Location [Axis]
Balance Sheet Location
Balance Sheet Location [Domain]
Other current liabilities
Other Current Liabilities [Member]
Other lease liabilities, non-current
Other Noncurrent Liabilities [Member]
Operating lease right-of-use asset
Operating lease, liability, current
Operating Lease Liability Current
Fair value disclosures line items.
Fair value disclosures.
Fair Value Disclosures [Table]
Fair Value Disclosures [Table]
Measurement Frequency
Fair Value By Measurement Frequency [Axis]
Measurement Frequency
Fair Value Measurement Frequency [Domain]
Fair Value Measurements Recurring Basis
Fair Value Measurements Recurring [Member]
Asset Class
Fair Value By Asset Class [Axis]
Asset Class
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Money Market Funds
Money Market Funds [Member]
Fair Value Hierarchy and NAV
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Fair Value Measurements Fair Value Hierarchy [Domain]
Level 1
Fair Value Inputs Level1 [Member]
Level 3
Fair Value Inputs Level3 [Member]
Liability Class
Fair Value By Liability Class [Axis]
Fair Value by Liability Class
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]
Contingent consideration.
Contingent Consideration
Contingent Consideration [Member]
Measurement Input Type
Measurement Input Type [Axis]
Measurement Input Type
Measurement Input Type [Domain]
Measurement Input, Discount Rate
Measurement Input Discount Rate [Member]
Measurement Input, Counterparty Credit Risk
Measurement Input Counterparty Credit Risk [Member]
Other Income, Net
Other Nonoperating Income Expense [Member]
Senior convertible notes eight point two percent due march thirty one two thousand twenty two.
8.2% Senior Convertible Notes Due 2022
Senior Convertible Notes Eight Point Two Percent Due March Thirty One Two Thousand Twenty Two [Member]
Fair Value Disclosures [Line Items]
Fair Value Disclosures [Line Items]
Unrealized gains and losses on investments
Unrealized Gain Loss On Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Restricted cash money market funds.
Restricted Cash (Money Market Funds)
Restricted Cash Money Market Funds [Member]
Level 1
Level 2
Fair Value Inputs Level2 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total financial assets
Assets Fair Value Disclosure
Total financial liabilities
Financial Liabilities Fair Value Disclosure
Transfers from Level 1 to Level 3
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
Transfers from Level 3 to Level 1
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
Fair value inputs increase (decrease) in probability of compound transaction payment occurrence.
Fair value investment measurement input
Business Combination Contingent Consideration Liability Measurement Input
Increase (decrease) in expected probability of compound transaction payment occurrence
Fair Value Inputs Increase Decrease In Probability Of Compound Transaction Payment Occurrence
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
Change in fair value of the contingent consideration liability
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
Ending balance
Fair value inputs probability of compound transaction payment occurrence.
Decrease in fair value of the compound transaction payment
Expected probability of compound transaction payment occurrence
Fair Value Inputs Probability Of Compound Transaction Payment Occurrence
Aggregate principal amount
Debt Instrument Face Amount
Convertible notes, interest rate
Debt Instrument Interest Rate Stated Percentage
Debt instrument maturity date
Debt Instrument Maturity Date
Debt instrument fair value
Debt Instrument Fair Value
Raw materials
Inventory Raw Materials
Work in process
Inventory Work In Process
Finished goods
Inventory Finished Goods
Total
Inventory Gross
Inventory current and noncurrent.
Total
Inventory Current And Noncurrent
Inventory Current [Table]
Inventory Current [Table]
Contract Manufacturing Organization.
Contract Manufacturing Organization
Contract Manufacturing Organization [Member]
Inventory [Line Items]
Inventory [Line Items]
Prepayment made for manufacturing services
Property Plant And Equipment [Abstract]
Construction in Progress
Construction In Progress [Member]
Total property and equipment
Property Plant And Equipment Gross
Accumulated depreciation and amortization
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Property and equipment, net
Accrued clinical and manufacturing liabilities current.
Payables And Accruals [Abstract]
Accrued clinical and manufacturing
Accrued Clinical And Manufacturing Liabilities Current
Accrued other
Other Accrued Liabilities Current
Accrued liabilities
Concentration of revenue.
Concentration of revenue.
Concentration Of Revenue [Table]
Concentration Of Revenue [Table]
Concentration of Revenue [Line Items]
Concentration Of Revenue [Line Items]
Net product revenue
Concentration Risk [Table]
Concentration Risk [Table]
Concentration Risk Benchmark
Concentration Risk By Benchmark [Axis]
Concentration Risk Benchmark
Concentration Risk Benchmark [Domain]
Net Product Revenue
Sales Revenue Net [Member]
Concentration Risk Type
Concentration Risk By Type [Axis]
Concentration Risk Type
Concentration Risk Type [Domain]
Customer Concentration Risk
Customer Concentration Risk [Member]
Customer
Major Customers [Axis]
Customer
Name Of Major Customer [Domain]
McKesson.
McKesson
Mc Kesson [Member]
AmeriSource-Bergen Corp.
AmeriSource-Bergen Corp
Ameri Source Bergen Corp [Member]
Cardinal.
Cardinal
Cardinal [Member]
Others
Other Customer [Member]
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Percentage of total revenue
Concentration Risk Percentage1
Reserve for sales discounts and allowances constitute variable consideration.
Payments and customer credits issued from reserve in discounts and allowances constitute variable consideration.
Reserve for discounts and allowances constitute variable consideration.
Product sales discounts and allowances.
Schedule of product sales discounts and allowances.
Schedule Of Product Sales Discounts And Allowances [Table]
Schedule Of Product Sales Discounts And Allowances [Table]
Other Fees, Co-pay Assistance and Returns
Valuation Allowances And Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves
Valuation Allowances And Reserves [Domain]
Charge backs and discounts for prompt payment.
Chargebacks and Discounts for Prompt Payment
Chargebacks And Discounts For Prompt Payment [Member]
Rebates.
Rebates
Rebates [Member]
Other fees, co-pay assistance and returns.
Other Fees, Co-pay Assistance and Returns
Other Fees Co Pay Assistance And Returns [Member]
Product Sales Discounts And Allowances [Line Items]
Product Sales Discounts And Allowances [Line Items]
Balance at December 31, 2018
Reserve For Discounts And Allowances Constitute Variable Consideration
Activity related to 2019 sales
Reserve For Sales Discounts And Allowances Constitute Variable Consideration
Payments and customer credits issued
Payments And Customer Credits Issued From Reserve For Discounts And Allowances Constitute Variable Consideration
Balance at December 31, 2019
Upfront and milestone payment receivable.
Additional milestone payments upon achievement of certain development and regulatory milestones.
Percentage of gross profits on sales.
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
Bioeq IP AG.
Bioeq IP AG
Bioeq I P A G [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Maximum
Maximum [Member]
Minimum [Member]
Minimum [Member]
Licensed Products
License [Member]
Daiichi Sankyo license agreement.
Daiichi Sankyo License Agreement
Daiichi Sankyo License Agreement [Member]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Upfront and milestone payment
Upfront And Milestone Payment
Additional milestone payments
Additional Milestone Payments Upon Achievement Of Certain Development And Regulatory Milestones
Percentage of gross profits on sales
Percentage Of Gross Profits On Sales
Collaboration and license revenue
Revenue From Contract With Customer Excluding Assessed Tax
Initial term of agreement.
Deferred revenue
Contract With Customer Liability
Initial term of agreement
Initial Term Of Agreement
Estimated period of performance upfront fee.
Estimated period of performance upfront fee
Estimated Period Of Performance Upfront Fee
Collaborative arrangement minimum percentage committed for clinical trial cost.
Minimum percentage of clinical trial cost
Collaborative Arrangement Minimum Percentage Committed For Clinical Trial Cost
Reimbursements of certain past costs incurred and to be incurred.
Reimbursement of past cost incurred and to be incurred
Reimbursement Of Costs Incurred And To Be Incurred
Research and development expenses reimbursed.
Research and development
Research And Development Expenses Reimbursed
Percentage of premium on convertible note.
Percentage of additional interest to be accrued upon failure of certain registration or reporting requirements.
8.2% Senior Convertible Notes Due March 2022
Maximum
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
Healthcare Royalty Partners III, L.P.
HRP III Member
Healthcare Royalty Partners I I I L P [Member]
Related Party
Related Party Transactions By Related Party [Axis]
Related Party
Related Party [Domain]
KKR Biosimilar L.P.
KKR Member
K K R Biosimilar L P [Member]
MX II Associates LLC.
MX II Member
M X I I Associates L L C [Member]
KMG Capital Partners, LLC.
KMGCP Member
K M G Capital Partners L L C [Member]
Proceeds from issuance of convertible notes
Proceeds From Convertible Debt
Convertible notes, Issuance Cost
Deferred Finance Costs Gross
Convertible notes, interest rate description
Debt Instrument Interest Rate Terms
Additional interest to be accrued upon failure of registration or reporting requirements
Percentage Of Additional Interest To Be Accrued Upon Failure Of Certain Registration Or Reporting Requirements
Convertible notes, premium percentage
Percentage Of Premium On Convertible Note
Debt instrument convertible number of shares per thousand of principal amount of notes.
Equivalent to conversion price per common share.
Principal amount of notes converted into shares of common stock at conversion rate.
Common shares at conversion
Debt Instrument Convertible Number Of Shares Per Thousand Of Principal Amount Of Notes
Conversion price per common share
Equivalent To Conversion Price Per Common Share
Principal amount of notes converted into shares
Principal Amount Of Notes Converted Into Shares Of Common Stock At Conversion Rate
Percentage of applicable conversion price.
Percentage to pay in cash of the par value of notes.
Percentage of applicable conversion price
Percentage Of Applicable Conversion Price
Convertible trading days
Debt Instrument Convertible Threshold Trading Days
Convertible consecutive trading days
Debt Instrument Convertible Threshold Consecutive Trading Days1
Percentage to pay in cash of the par value of notes
Percentage To Pay In Cash Of Par Value Of Notes
Minimum order amount to be settled.
Minimum borrowings for indebtedness defaulters.
Minimum order amount to be settled
Minimum Order Amount To Be Settled
Minimum borrowings for indebtedness defaulters
Minimum Borrowings For Indebtedness Defaulters
Convertible notes, covenant compliance
Debt Instrument Covenant Compliance
Consolidated Entities
Consolidated Entities [Axis]
Consolidated Entities
Consolidated Entities [Domain]
Parent Company
Parent Company [Member]
Long-term Debt, Type
Longterm Debt Type [Axis]
Long-term Debt, Type
Longterm Debt Type [Domain]
Related party debt.
Related Party Debt
Related Party Debt [Member]
Principal amount of the Convertible Notes
Unamortized debt discount and debt issuance costs
Debt Instrument Unamortized Discount Premium Net
Convertible Notes
Convertible Notes - related parties
Total Convertible Notes
Convertible Notes Payable
Convertible notes, converted amount
Debt Conversion Converted Instrument Amount1
Closing stock, price per share
Share Price
Stated coupon interest
Interest Expense Debt Excluding Amortization
Accretion of debt discount and debt issuance costs
Interest expense
Interest Expense Debt
Interest expense
Total interest expense
Unamortized debt discount and debt issuance costs on Convertible Notes
Amortized effective interest rate convertible notes period
Debt Instrument Convertible Remaining Discount Amortization Period1
Effective interest rate
Debt Instrument Interest Rate Effective Percentage
2020
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
2021
Long Term Debt Maturities Repayments Of Principal In Year Two
2022
Long Term Debt Maturities Repayments Of Principal In Year Three
Total minimum payments
Debt Instrument Carrying Amount
Less amount representing interest
Interest Payable Current And Noncurrent
Convertible Notes, principal amount
Convertible Notes Principal Amount
Less debt discount and debt issuance costs on Convertible Notes
Net carrying amount
Long Term Debt
Subsequent Event Type
Subsequent Event Type [Axis]
Subsequent Event Type
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Member]
Variable Rate
Variable Rate [Axis]
Variable Rate
Variable Rate [Domain]
LIBOR
London Interbank Offered Rate L I B O R [Member]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
Scenario Forecast
Scenario Forecast [Member]
Credit Facility
Credit Facility [Axis]
Credit Facility
Credit Facility [Domain]
Prepayment premium condition one.
Paid on or Prior to the Three Year Anniversary of Closing Date
Prepayment Premium Condition One [Member]
Prepayment premium condition two.
Paid after the Three Year but on or Prior to the Four Year Anniversary of Closing Date
Prepayment Premium Condition Two [Member]
Prepayment premium condition three.
Paid after the Four Year but on or Prior to the Five Year Anniversary of Closing Date
Prepayment Premium Condition Three [Member]
Prepayment premium condition four.
Paid Thereafter
Prepayment Premium Condition Four [Member]
Minimum
Term loan facility term
Debt Instrument Term
Net sales
Debt instrument prepayment premium, description.
Debt instrument prepayment percentage.
Prepayment premium, description
Debt Instrument Prepayment Premium Description
Prepayment premium percentage
Debt Instrument Prepayment Percentage
Payment to lender for closing fee in form of origination discount.
Percentage required to pay an additional exit fee on principal amount.
Payment of closing fee to the lenders in form of origination issue discount
Payment To Lender For Closing Fee In Form Of Origination Issue Discount
Percentage required to pay an additional exit fee on principal amount
Percentage Required To Pay Additional Exit Fee On Principal Amount
Revenue from contract with customer excluding assessed tax in next twelve months.
Revenue from contract with customer excluding assessed tax in year two.
Revenue from contract with customer excluding assessed tax thereafter.
Consolidated net sales, 2019
Revenue From Contract With Customer Excluding Assessed Tax In Next Twelve Months
Consolidated net sales, 2020
Revenue From Contract With Customer Excluding Assessed Tax In Year Two
Consolidated net sales, thereafter
Revenue From Contract With Customer Excluding Assessed Tax Thereafter
Principal amount of the Term Loan
Unamortized debt discount and debt issuance costs
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
Unamortized debt discount and debt issuance costs on Term Loan
Amortized effective interest rate Term Loan period
2023
Long Term Debt Maturities Repayments Of Principal In Year Four
2024 and beyond
Long Term Debt Maturities Repayments Of Principal After Year Five
Term Loan, gross
Term Loan Gross
2020
Purchase Obligation Due In Next Twelve Months
2021
Purchase Obligation Due In Second Year
2022
Purchase Obligation Due In Third Year
Total obligations
Purchase Obligation
Contractual Obligation Fiscal Year Maturity [Abstract]
Loss Contingencies [Table]
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Lease expiration date, month and year.
Operating leases extended expiration period.
Lessee Lease Description [Table]
Lessee Lease Description [Table]
Lease Arrangement, Type
Lease Arrangement Type [Axis]
Lease Arrangement, Type
Lease Arrangement Type [Domain]
Corporate headquarters lease agreement.
Corporate Headquarters Lease
Corporate Headquarters Lease Agreement [Member]
Laboratory facilities lease agreement.
Laboratory Facilities Lease
Laboratory Facilities Lease Agreement [Member]
New Camarillo Lease.
New Camarillo Lease
New Camarillo Lease [Member]
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Area of office space leased
Area Of Real Estate Property
Aggregate tenant improvement allowance
Tenant Improvements
Lease expiration date
Lease Expiration Date Month And Year
Leases extended expiration period
Operating Leases Extended Expiration Period
Number of laboratory facility structure.
Extended lease term date one.
Extended lease term date two.
Number of laboratory facility structure
Number Of Laboratory Facility Structure
Extended lease term date one
Extended Lease Term Date One
Extended lease term date two
Extended Lease Term Date Two
Additional area of real estate property leased.
Additional area of office space leased
Additional Area Of Real Estate Property Leased
Area of laboratory facility.
Area of laboratory facility
Area Of Laboratory Facility
Future minimum rental payments
Operating Leases Future Minimum Payments Due
Operating lease liabilities.
Operating lease liabilities
Operating Lease Liabilities [Abstract]
Other current liabilities
Total operating lease liabilities
Operating Lease Liability
Cash paid for amounts included in measurement of lease liabilities
Operating Lease Payments
Operating Lease Liabilities Payments Due [Abstract]
2020
Lessee Operating Lease Liability Payments Due Next Twelve Months
2021
Lessee Operating Lease Liability Payments Due Year Two
2022
Lessee Operating Lease Liability Payments Due Year Three
2023
Lessee Operating Lease Liability Payments Due Year Four
2024
Lessee Operating Lease Liability Payments Due Year Five
Total lease payments
Lessee Operating Lease Liability Payments Due
Less imputed interest
Lessee Operating Lease Liability Undiscounted Excess Amount
Operating lease liabilities
Weighted average remaining lease term
Operating Lease Weighted Average Remaining Lease Term1
Weighted average operating discount rate
Operating Lease Weighted Average Discount Rate Percent
Rent expense
Operating Lease Expense
2019
Operating Leases Future Minimum Payments Due Current
2020
Operating Leases Future Minimum Payments Due In Two Years
2021
Operating Leases Future Minimum Payments Due In Three Years
2022
Operating Leases Future Minimum Payments Due In Four Years
Total minimum lease payments
Maximum amount sales agent may sell common stock.
Percentage of gross sales proceeds of common stock payable as compensation.
Payments for commission and offering expenses.
Schedule Of Stock By Class [Table]
Schedule Of Stock By Class [Table]
At-the-market equity offering program.
At-the-Market Equity Offering Program
At The Market Equity Offering Program [Member]
Cowen and Company, LLC.
Cowen and Company LLC
Cowen And Company L L C [Member]
Underwritten public offering.
Underwritten Public Offering
Underwritten Public Offering [Member]
Underwriters' Option to Purchase Additional Shares
Over Allotment Option [Member]
Class Of Stock [Line Items]
Class Of Stock [Line Items]
Maximum amount of sales that agent may sell in shares of its common stock
Maximum Amount Sales Agent May Sell Common Stock
Percentage of gross sales proceeds of common stock payable as compensation
Percentage Of Gross Sales Proceeds Of Common Stock Payable As Compensation
Common stock, shares issued and sold
Share price
Shares Issued Price Per Share
Gross proceeds from issuance of common stock
Proceeds From Issuance Of Common Stock
Underwriting discounts and commissions
Payments For Underwriting Expense
Offering expense
Payments For Commission And Offering Expenses
Common stock, net proceeds
Sale Of Stock Consideration Received On Transaction
Rate of increase in number of common stock available for issuance.
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Two thousand and fourteen equity incentive award plan.
2014 Equity Incentive Award Plan
Two Thousand And Fourteen Equity Incentive Award Plan [Member]
Employee Stock Option
Employee Stock Option [Member]
2017 Bonus payout settled in RSU’s.
Two Thousand Seventeen Bonus Payout Settled In Restricted Stock Units RSUs
Two Thousand Seventeen Bonus Payout Settled In Restricted Stock Units R S Us [Member]
Performance stock options.
Performance Stock Options
Performance Stock Options [Member]
Nonemployees stock based compensation.
Nonemployees Stock-Based Compensation
Nonemployees Stock Based Compensation [Member]
Two thousand and fourteen employee stock purchase plan.
2014 Employee Stock Purchase Plan
Two Thousand And Fourteen Employee Stock Purchase Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of shares available for issuance
Rate Of Increase In Number Of Common Tock Available For Issuance
Common stock reserved for future issuance
Common Stock Capital Shares Reserved For Future Issuance
Vesting period
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
Options, expiration period
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
Number of Options, Beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Number of Options, Granted - at fair value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Number of Options, Exercised
Number of Options, Forfeited /Cancelled
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Number of Options, Ending balance
Weighted-Average Exercise Price, Beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Weighted-Average Exercise Price, Granted - at fair value
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Weighted-Average Exercise Price, Exercised
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Weighted-Average Exercise Price, Forfeited /Cancelled
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Weighted-Average Exercise Price, Ending balance
Options outstanding, Number of Options
Options vested and exercisable, Number of Options
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
Options outstanding, Weighted-Average Exercise Price
Options vested and exercisable, Weighted-Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
Options outstanding, Weighted-Average Contractual Terms
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Options vested and exercisable, Weighted-Average Contractual Terms
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
Options outstanding, Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Options vested and exercisable, Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
Options granted, weighted-average grant-date fair value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Options exercised, aggregate intrinsic value
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Stock-based compensation expense
Allocated Share Based Compensation Expense
Unrecognized stock-based compensation expenses related to stock options
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Unrecognized share-based compensation related to stock options, RSUs and ESPP, period for recognition
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Number of RSU's, Balances at December 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Number of RSU's granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Number of RSU's vested
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Number of RSU's cancelled
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Number of RSU's, Balances at December 31, 2019
Weighted-Average Grant Date Fair Value, Balances at December 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, RSU's granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, RSU's Vested
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, RSU's cancelled
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Balances at December 31, 2019
Share based compensation arrangement by share based payment award equity instruments other than options grants in period estimated grant date fair value.
Total fair value of RSUs vested
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
Total estimated grant date fair value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Estimated Grant Date Fair Value
Estimated weighted-average grant-date fair value of RSUs granted
Unrecognized stock-based compensation expenses related to unvested RSUs
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
Share based payment RSUs grants
Share based payment options grants
Weighted-average exercise price of options granted
Rate of increase in number of common stock outstanding reserve for future issuance.
Employee service share based compensation offering period one.
Employee service share based compensation offering period two.
Percentage of shares reserve for issuance
Rate Of Increase In Number Of Common Stock Outstanding Reserve For Future Issuance
Percentage of purchase common stock of lesser of fair market value of common stock on first or last day of offering period by eligible employees
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
Employee stock purchase plan offering period one
Employee Service Share Based Compensation Offering Period One
Employee stock purchase plan offering period two
Employee Service Share Based Compensation Offering Period Two
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Cost of Goods Sold
Cost Of Sales [Member]
General and Administrative Expense
General And Administrative Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Capitalized stock-based compensation expense into inventory
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
Stock Options
ESPP
Expected term (years)
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Expected volatility
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Risk-free interest rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
Expected dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Expected dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
Defined contribution plan employer matching contribution of each participant's contribution plan.
Defined contribution plan name
Defined Contribution Plan Plan Name
Percentage of maximum contribution of annual compensation
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
Percentage of employer matching contributions
Defined Contribution Plan Employer Matching Contribution Percent Of Match
Employer matching contribution of each participant's contribution plan
Defined Contribution Plan Employer Matching Contribution Of Each Participants Contribution Plan
Compensation expense related to match plan
Defined Contribution Plan Cost Recognized
Schedule Of Restructuring And Related Costs [Table]
Schedule Of Restructuring And Related Costs [Table]
Restructuring Type
Restructuring Cost And Reserve [Axis]
Type of Restructuring
Type Of Restructuring [Domain]
Termination severance and related cost.
Termination Severance and Related Costs
Termination Severance And Related Cost [Member]
Selling, General and Administrative Expenses
Selling General And Administrative Expenses [Member]
Restructuring Cost And Reserve [Line Items]
Restructuring Cost And Reserve [Line Items]
Aggregate restructuring charges
Restructuring Charges
Non-cash stock-based compensation expense
Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
Payments for personnel-related restructuring charges
Payments For Restructuring
Restructuring liabilities
Restructuring Reserve
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments [Abstract]
Domestic
Income Loss From Continuing Operations Before Income Taxes Domestic
Foreign
Income Loss From Continuing Operations Before Income Taxes Foreign
Total
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward
Current
Current Income Tax Expense Benefit Continuing Operations [Abstract]
Federal
Current Federal Tax Expense Benefit
State
Current State And Local Tax Expense Benefit
Foreign
Current Foreign Tax Expense Benefit
Subtotal
Current Income Tax Expense Benefit
Deferred
Deferred Income Tax Expense Benefit Continuing Operations [Abstract]
Federal
Deferred Federal Income Tax Expense Benefit
State
Deferred State And Local Income Tax Expense Benefit
Foreign
Deferred Foreign Income Tax Expense Benefit
Subtotal
Deferred Income Tax Expense Benefit
Provision for income taxes
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Table]
Income Tax Authority
Income Tax Authority [Axis]
Income Tax Authority
Income Tax Authority [Domain]
Federal
Domestic Country [Member]
State
State And Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards [Line Items]
Income tax provision
Effective income tax rate reconciliation permanent differences.
Effective income tax rate reconciliation tax (expense) and credits research.
Effective income tax rate reconciliation net operating losses.
Effective income tax rate reconciliation change in tax reform tax rate.
Income taxes.
Income taxes.
Income Taxes [Table]
Income Taxes [Table]
Accounting Standards Update 2016-09
Accounting Standards Update201609 [Member]
Income Taxes [Line Items]
Income Taxes [Line Items]
Percent of pre-tax income:
Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract]
U.S. federal statutory income tax rate
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
State taxes, net of federal benefit
Effective Income Tax Rate Reconciliation State And Local Income Taxes
Foreign rate differences
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
Permanent items
Effective Income Tax Rate Reconciliation Permanent Differences
Research and development credit
Effective Income Tax Rate Reconciliation Tax Expense And Credits Research
Effect in NOLs due to adoption of ASU 2016-09
Effective Income Tax Rate Reconciliation Net Operating Losses
U.S. Tax Reform tax rate change
Effective Income Tax Rate Reconciliation Change In Tax Reform Tax Rate
Other
Effective Income Tax Rate Reconciliation Other Adjustments
Change in valuation allowance
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
Effective income tax rate
Effective Income Tax Rate Continuing Operations
Deferred tax liabilities right of use asset.
Deferred tax assets before valuation allowance net of deferred tax liabilities.
Components Of Deferred Tax Assets [Abstract]
Net operating loss carryforwards
Deferred Tax Assets Operating Loss Carryforwards
Research and development credits
Deferred Tax Assets Tax Credit Carryforwards Research
Depreciation and amortization
Deferred Tax Assets Property Plant And Equipment
Stock-based compensation
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
Sales related accruals
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
Other accruals
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
Gross deferred tax assets
Deferred Tax Assets Gross
Right-of-use asset
Deferred Tax Liabilities Right Of Use Asset
In-process research and development
Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
Gross deferred tax liabilities
Deferred Tax Liabilities
Total net deferred tax asset
Deferred Tax Asset Liability Net
Less valuation allowance
Deferred Tax Assets Valuation Allowance
Net deferred tax assets
Deferred Tax Assets Liabilities Net
Increase (decrease) in valuation allowance
Valuation Allowance Deferred Tax Asset Change In Amount
Operating loss carryforwards expiration year.
Net operating loss carryforwards
Operating Loss Carryforwards
Net operating loss carryforwards expiration year
Operating Loss Carryforwards Expiration Year
Tax credit carryforward expiration year.
Tax credit carryforwards
Tax Credit Carryforward Amount
Tax credit carryforwards expiration year
Tax Credit Carryforward Expiration Year
Unrecognized tax benefits increase decrease resulting from prior period tax positions.
Balance at beginning of year
Unrecognized Tax Benefits
Additions based on tax positions related to current year
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Additions (reductions) for tax positions of prior years
Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
Balance at end of year
Unrecognized tax benefits, accrued interest and penalties accrued
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
Unrecognized tax benefits
Basic net income (loss) per share
Earnings Per Share Basic [Abstract]
Numerator:
Net Income Loss [Abstract]
Denominator:
Weighted Average Number Of Shares Outstanding Basic [Abstract]
Weighted-average common shares outstanding
Weighted Average Number Of Share Outstanding Basic And Diluted
Basic net income (loss) per share attributable to Coherus
Diluted net income (loss) per share
Earnings Per Share Diluted [Abstract]
Numerator:
Net Income Loss Attributable To Parent Diluted [Abstract]
Numerator for diluted net income (loss) per share attributable to Coherus
Net Income Loss Attributable To Parent Diluted
Denominator:
Denominator for basic net income (loss) per share attributable to Coherus
Add effect of potential dilutive securities:
Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]
Stock options, including purchases from contributions to ESPP
Incremental Common Shares Attributable To Share Based Payment Arrangements
Restricted stock units
Incremental Common Shares Attributable To Contingently Issuable Shares
Denominator for diluted net income (loss) per share attributable to Coherus
Weighted Average Number Diluted Shares Outstanding Adjustment
Diluted net income (loss) per share attributable to Coherus
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Employees and non-employees stock option.
Stock Options, Including Purchases from Contributions to ESPP
Employees And Nonemployees Stock Option [Member]
Convertible notes.
Shares Issuable Upon Conversion of Convertible Notes
Convertible Notes [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from the calculation of diluted net loss per share
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Schedule Of Related Party Transactions By Related Party [Table]
Schedule Of Related Party Transactions By Related Party [Table]
Medpace Inc.
Medpace Inc
Medpace Inc [Member]
Related Party Transaction
Related Party Transaction [Axis]
Related Party Transaction
Related Party Transaction [Domain]
Recruiting services.
Recruiting Services
Recruiting Services [Member]
Board of Directors
Board Of Directors Chairman [Member]
Affiliated Entity
Affiliated Entity [Member]
Chief Executive Officer
Chief Executive Officer [Member]
Inte Krin Russia.
InteKrin Russia
Inte Krin Russia [Member]
Ownership
Ownership [Axis]
Ownership
Ownership [Domain]
Dennis M. Lanfear.
Mr. Lanfear
Dennis M Lanfear [Member]
Title of Individual
Title Of Individual [Axis]
Title of Individual
Title Of Individual With Relationship To Entity [Domain]
Chief executive officer and board of director.
Mr. Lanfear
Chief Executive Officer And Board Of Director [Member]
RUSSIA
RUSSIAN FEDERATION
InteKrin Therapeutics Inc
Subsidiaries [Member]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Research and development expense
Related party balances
Due To Related Parties Current And Noncurrent
Business combination consideration transferred
Business Combination Consideration Transferred1
Related party transaction ownership percentage
Minority Interest Ownership Percentage By Noncontrolling Owners
Business combination securities acquired percentage.
Payments to acquire securities of non-controlling interest in subsidiary
Percentage of securities acquired
Business Combination Securities Acquired Percentage
Consideration received for shares
Sale Of Stock Consideration Received Per Transaction
License agreement upfront payment.
Aggregate milestone payment in connection with achievement of certain development regulatory and sales milestones.
Option exercise fess.
Technology transfer for manufacturing of licensed product fees.
Subsequent Event [Table]
Subsequent Event [Table]
License Agreement Innovent Biologics (Suzhou) Company Limited.
Innovent Biologics (Suzhou) Company Limited License Agreement
Innovent Biologics Suzhou Company Limited License Agreement [Member]
Subsequent Event [Line Items]
Subsequent Event [Line Items]
License agreement upfront payment
License Agreement Upfront Payment
Aggregate milestone payment in connection with achievement of certain development, regulatory and sales milestones.
Aggregate Milestone Payment In Connection With Achievement Of Certain Development Regulatory And Sales Milestones
Option exercise fess
Option Exercise Fess
Technology transfer for the manufacturing of licensed product related fees
Technology Transfer For Manufacturing Of Licensed Product Fees
Total revenue
Gross profit
Gross Profit
Total operating expenses
Net loss per share attributable to Coherus, basic and diluted
Earnings Per Share Basic And Diluted